Vaibhav Aher

Thrombolytic studies of Streptokinase from Streptococcus pyogenes

Streptokinase as a thrombolytic agent

• Broschiertes Buch

Produktbeschreibung

Life would not long remain possible in the absence of microbes. Many of common problems in clinical practice today relate to thrombosis. Streptokinase is the first thrombolytic drug to be described and was introduced for myocardial infarction more than 40 years ago. It is now the leading thrombolytic agent and is included in the World Health Organization (WHO) model list of essential medicine. A failure of hemostasis and consequent development of blood clots in the circulatory system can produce severe consequences such as acute myocardial infarction and ischemic stroke, both leads to cause of death. Pathological development of blood clots requires clinical intervention with fibrinolytic agents such as tissue plasminogen activator and streptokinase. This book deals with streptokinase as a clinically important and plasminogen activator by the studies.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: LAP Lambert Academic Publishing
• Seitenzahl: 84
• Erscheinungstermin: 21. Juni 2016
• Englisch
• Abmessung: 220mm x 150mm x 6mm
• Gewicht: 143g
• ISBN-13: 9783659909467
• ISBN-10: 3659909467
• Artikelnr.: 45288316

Autorenporträt

Dr. Vaibhav Dagaji Aher completed bachelors in Pharmacy, Masters in Pharmaceutical Biotechnology, PhD in Pharmaceutical Sciences and has Postdoctoral research experience from India and USA in the field of immunology, toxicology, radiation health.